Infectious Diseases News and Research

RSS

MAPS method could speed development of new vaccines for serious pathogens

A new method of vaccine design, called the Multiple Antigen Presentation System, may result in vaccines that bring together the benefits of whole-cell and acellular or defined subunit vaccination.

1 Aug 2013

BD reports quarterly revenues of $2.053 billion for third fiscal quarter

BD (Becton, Dickinson and Company), a leading global medical technology company, today reported quarterly revenues of $2.053 billion for the third fiscal quarter ended June 30, 2013, representing an increase of 3.6 percent from the prior-year period, or 5.1 percent on a foreign currency-neutral basis.

From BD (Becton, Dickinson and Company) 1 Aug 2013

Prevention against EEE and West Nile virus is within everyone's control

Every year reported cases of Eastern Equine Encephalitis and the West Nile virus surface in communities around the country, raising concerns and questions about mosquito borne-illnesses. Despite reports that children and the elderly are at greatest risk, anyone can be stricken by these viruses. But prevention is within everyone's control.

1 Aug 2013

NIH-funded study finds that rituximab is as effective as standard therapy for severe vasculitis

Administering the drug rituximab once weekly for one month provides the same benefits as 18 months of daily immunosuppressive therapy in people with severe forms of vasculitis, or inflammation of the blood vessels, a study has found.

1 Aug 2013

CWRU grants technology transfer option to Disease Diagnostic Group to evaluate RAM device

Case Western Reserve University has granted a two-year technology transfer option to a research spinoff company developing a hand-held device that diagnoses malaria more quickly, simply and affordably than existing methods.

31 Jul 2013

Baxter, JW Holdings sign distribution, license agreement for omega 3 parenteral nutrition products

Baxter International Inc. and JW Holdings today announced that they have entered into an exclusive distribution and license agreement for parenteral nutritional products containing a novel formulation of omega 3 lipids.

From Baxter International Inc. 31 Jul 2013

FibroGen, Astellas initiate Phase 2 study of ASP1517/FG-4592 for treatment of anemia linked with CKD

Astellas Pharma Inc. (Tokyo:4503) (Astellas) and FibroGen, Inc. (FibroGen) announced today the initiation of a Phase 2 clinical study in Japan of ASP1517/FG-4592 for treatment of anemia associated with chronic kidney disease (CKD) in patients on dialysis.

31 Jul 2013

Tick-borne diseases on the rise in US

With the summer months upon us, Lyme disease and other tick-borne illnesses are on the rise in the United States. According to the U.S. Centers for Disease Control and Prevention, tick-borne diseases are increasing, with human cases expected to exceed 300,000 annually.

30 Jul 2013

Interferon-free treatment for genotype-1b hepatitis C patients: an interview with Professor Wulf Boecher, Boehringer Ingelheim

Genotype 1 is, worldwide, the most prevalent genotype of the hepatitis C virus. It accounts for around seventy percent of all hepatitis C infections.

30 Jul 2013

Genistein derived from soybeans shows promise in inhibiting HIV infection

A compound found in soybeans may become an effective HIV treatment without the drug resistance issues faced by current therapies, according to new research by George Mason University researchers.

30 Jul 2013

Saudi and UK scientists provide detailed picture of MERS coronavirus

Saudi and UK scientists provide the most detailed picture yet of the clinical and laboratory characteristics of Middle East Respiratory Syndrome (MERS) coronavirus, revealing a wide range of clinical symptoms and an extremely high death rate among patients with co-existing medical conditions.

29 Jul 2013

Trovagene adopts RainDance's RainDrop digital PCR system for eventual use in CLIA laboratory

Trovagene, Inc. (NASDAQ: TROV) and RainDance Technologies announced today that Trovagene has adopted RainDance's RainDropTM Digital PCR System for research and development, and for eventual use in the Trovagene CLIA laboratory.

29 Jul 2013

New method can pinpoint DNA mutations that could help treat cancer, tuberculosis

The slightest variation in a sequence of DNA can have profound effects. Modern genomics has shown that just one mutation can be the difference between successfully treating a disease and having it spread rampantly throughout the body.

29 Jul 2013

Miriam researcher calls for new strategies to better manage, improve treatment for HCV infection

A Miriam Hospital researcher has joined forces with international colleagues to call for new strategies to better manage and improve assessment and treatment for hepatitis C (HCV) infection in individuals who inject drugs.

26 Jul 2013

Zydus, IDRI partner to develop visceral leishmaniasis vaccine candidate

In a unique partnership, Zydus, India's fourth largest healthcare group and an innovation-led global healthcare provider, and IDRI, a Seattle-based non-profit research and product development organization, announced today they are collaborating on the production and clinical development of IDRI's visceral leishmaniasis vaccine candidate, designed to prevent the deadly parasitic disease.

26 Jul 2013

First lots of 2013-2014 seasonal influenza vaccine released for U.S. distribution

Sanofi Pasteur, the vaccines division of Sanofi, announced today that the first lots of Fluzone (Influenza Virus Vaccine) for the 2013-2014 season have been released by the U.S. Food and Drug Administration for U.S. distribution and were shipped July 24.

25 Jul 2013

Secretary of State for BIS designates LSTM as higher education institution

The Secretary of State for Business, Innovation and Skills (BIS) has, by an Order in Parliament under section 129 of the Education Reform Act 1988, designated the Liverpool School of Tropical Medicine (LSTM) as a higher education institution (HEI) eligible to receive funding direct from the Higher Education Funding Council for England (HEFCE).

25 Jul 2013

PerkinElmer enhances Operetta imaging system to perform live cell assays with higher throughput

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, has announced enhancements for its Operetta® High Content Imaging System, designed to significantly improve the ability of scientists to perform live cell assays with higher throughput, to help foster a better understanding of normal and aberrant cellular behavior.

25 Jul 2013

Combination treatment can reduce hepatitis C infection in people who inject drugs

The burden of liver disease could be dramatically reduced by scaling up the combination of interventions for hepatitis C infection among people who inject drugs according to University of Bristol researchers. The findings, published today [24 July], form part of new global recommendations on treating the virus.

25 Jul 2013

NIAID researchers discover monoclonal antibody can neutralize human norovirus

Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) provide the first proof of concept data showing that a monoclonal antibody can neutralize human norovirus. This research, which could one day lead to effective therapies against the virus, was published online ahead of print in the Journal of Virology.

25 Jul 2013

Infectious Diseases News and Research

MAPS method could speed development of new vaccines for serious pathogens

BD reports quarterly revenues of $2.053 billion for third fiscal quarter

Prevention against EEE and West Nile virus is within everyone's control

NIH-funded study finds that rituximab is as effective as standard therapy for severe vasculitis

CWRU grants technology transfer option to Disease Diagnostic Group to evaluate RAM device

Baxter, JW Holdings sign distribution, license agreement for omega 3 parenteral nutrition products

FibroGen, Astellas initiate Phase 2 study of ASP1517/FG-4592 for treatment of anemia linked with CKD

Tick-borne diseases on the rise in US

Interferon-free treatment for genotype-1b hepatitis C patients: an interview with Professor Wulf Boecher, Boehringer Ingelheim

Genistein derived from soybeans shows promise in inhibiting HIV infection

Saudi and UK scientists provide detailed picture of MERS coronavirus

Trovagene adopts RainDance's RainDrop digital PCR system for eventual use in CLIA laboratory

New method can pinpoint DNA mutations that could help treat cancer, tuberculosis

Miriam researcher calls for new strategies to better manage, improve treatment for HCV infection

Zydus, IDRI partner to develop visceral leishmaniasis vaccine candidate

First lots of 2013-2014 seasonal influenza vaccine released for U.S. distribution

Secretary of State for BIS designates LSTM as higher education institution

PerkinElmer enhances Operetta imaging system to perform live cell assays with higher throughput

Combination treatment can reduce hepatitis C infection in people who inject drugs

NIAID researchers discover monoclonal antibody can neutralize human norovirus

Industry Focus: Infectious Diseases eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News